Molecular mechanisms of dopaminergic neurodegeneration: genetic and environmental basis.
Imam
Syed Z
SZ
Division of Neurotoxicology, US FDA/NCTR, Jefferson, Arkansas 72079, USA.
D000818:Animals; D004268:DNA-Binding Proteins / Q000235:genetics / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism*; D006801:Humans; D051379:Mice; D008875:Middle Aged; D009474:Neurons / Q000378:metabolism* / Q000473:pathology*; D009569:Nitric Oxide / Q000378:metabolism; D057126:Nuclear Receptor Subfamily 4, Group A, Member 2; D010300:Parkinson Disease / Q000235:genetics / Q000378:metabolism* / Q000473:pathology; D051381:Rats; D012402:Rotenone / Q000378:metabolism; D014157:Transcription Factors / Q000235:genetics / Q000378:metabolism; D014475:Uncoupling Agents / Q000378:metabolism
D004268:DNA-Binding Proteins; C539882:NR4A2 protein, human; C539883:Nr4a2 protein, mouse; C539884:Nr4a2 protein, rat; D057126:Nuclear Receptor Subfamily 4, Group A, Member 2; D014157:Transcription Factors; D014475:Uncoupling Agents; D012402:Rotenone; D009569:Nitric Oxide; D004298:Dopamine